Core Viewpoint - The announcement from Longbo Technology indicates that significant shareholders plan to reduce their holdings, which is primarily driven by personal financial needs, but it is not expected to impact the company's governance structure or ongoing operations significantly [1] Summary by Relevant Sections - **Shareholder Actions** - The controlling shareholder and actual controller's concerted actors, Fan Xiaoyou and Wang Shuguang, plan to reduce their holdings by a maximum of 80,000 shares and 25,000 shares, respectively [1] - These reductions represent up to 0.0755% and 0.0236% of the company's total share capital [1] - **Reason for Reduction** - The reason cited for the share reduction is personal funding needs [1] - **Impact on Company** - The company anticipates that these share reductions will not have a significant impact on its governance structure or its ongoing operations [1]

Core Viewpoint - Longbo Technology (603655.SH) announced a share reduction plan involving its controlling shareholder and actual controller's concerted action person, Fan Xiaoyou, and company director and vice president, Wang Shuguang [1] Shareholding Details - Before the share reduction plan, Fan Xiaoyou held 80,000 unrestricted circulating shares, accounting for 0.0755% of the company's total share capital, acquired prior to the company's IPO [1] - Wang Shuguang held 100,000 unrestricted circulating shares, accounting for 0.0943% of the company's total share capital, also acquired before the IPO [1] Reduction Plan - Fan Xiaoyou plans to reduce his holdings by no more than 80,000 shares, representing up to 0.0755% of the total share capital, through centralized bidding within three months after 15 trading days from the announcement [1] - Wang Shuguang intends to reduce his holdings by no more than 25,000 shares, representing up to 0.0236% of the total share capital, also through centralized bidding within the same timeframe [1]

1.自本次减持计划公告之日起15个交易日后的3个月内，范小友先生拟通过集中竞价交易方式减持股份 数量不超过80,000股，占公司总股本不超过0.0755%，减持价格将根据减持时的二级市场价格确定。2. 自本次减持计划公告之日起15个交易日后的3个月内，王曙光先生拟通过集中竞价交易方式减持股份数 量不超过25,000股，占公司总股本不超过0.0236%，减持价格将根据减持时的二级市场价格确定。 格隆汇9月4日丨朗博科技(603655.SH)公布，本次减持计划实施前，控股股东及实际控制人的一致行动 人范小友先生持有常州朗博密封科技股份有限公司无限售流通股份80,000股，占公司总股本的 0.0755%。上述股份来源于公司首次公开发行股票前取得的股份。本次减持计划实施前，控股股东及实 际控制人的一致行动人兼公司董事、副总经理王曙光先生持有公司无限售流通股份100,000股，占公司 总股本的0.0943%。上述股份来源于公司IPO前取得的股份。 ...

证券代码：603655 证券简称：朗博科技 公告编号：2025-037 减持主体持股的基本情况 1．本次减持计划实施前，控股股东及实际控制人的一致行动人范小友先生 持有常州朗博密封科技股份有限公司（以下简称"公司"）无限售流通股份80,000 股，占公司总股本的0.0755%。上述股份来源于公司首次公开发行股票（以下简 称"IPO"）前取得的股份。 2．本次减持计划实施前，控股股东及实际控制人的一致行动人兼公司董事、 副总经理王曙光先生持有公司无限售流通股份100,000股，占公司总股本的 0.0943%。上述股份来源于公司IPO前取得的股份。 减持计划的主要内容 1.自本次减持计划公告之日起15个交易日后的3个月内，范小友先生拟通过 集中竞价交易方式减持股份数量不超过80,000股，占公司总股本不超过0.0755%， 减持价格将根据减持时的二级市场价格确定。 常州朗博密封科技股份有限公司 控股股东及实际控制人的一致行动人 减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 2.自本次减 ...

朗博科技公告，两位控股股东及实际控制人的一致行动人披露减持计划：范小友拟于2025年9月29日至 12月28日通过集中竞价减持不超过80000股，占0.0755%；王曙光拟同期通过集中竞价减持不超过25000 股，占0.0236%。 ...

Group 1 - The core point of the announcement is that Longbo Technology has declared a cash dividend of 0.09 yuan per share (tax included) for the first half of 2025 [2] - The record date for the dividend is set for September 8, 2025, and the ex-dividend date is September 9, 2025 [2] - This profit distribution will only involve cash dividends and does not include stock bonuses or capital reserve transfers to increase share capital [2]

Group 1 - Weisheng Information won four projects in August with a total amount of 85.5377 million yuan, accounting for 3.12% of the company's total revenue for 2024 [1] - Longqi Technology's shareholder plans to reduce its stake by up to 4.09%, equating to a maximum of 19.1916 million shares [1] - Guojin Modern's subsidiary received a drug registration certificate for injectable Nicardipine, used for treating unstable angina [3][4] Group 2 - SAIC Motor reported a total vehicle sales of 363,400 units in August, a year-on-year increase of 41.04%, with new energy vehicle sales reaching 129,800 units, up 49.89% [5] - Kuka Home plans to invest 1.124 billion yuan to build a self-owned base in Indonesia, aiming to enhance its international strategy [6] - Samsung Medical's subsidiary signed a contract for an intelligent meter project in Egypt worth 58.8 million USD, approximately 419 million yuan [8] Group 3 - North Vehicle Blue Valley's subsidiary reported a total production of 10,587 units in August, a year-on-year decrease of 15.13%, while sales increased by 3.47% [12] - Xianghe Industrial signed contracts worth 400 million yuan for railway fastener system components [13] - Hengrui Medicine's HRS9531 injection has received acceptance for its marketing authorization application [14] Group 4 - Hualu Hengsheng resumed normal production after completing maintenance on production facilities [16] - Shanghai Pharmaceuticals' hydrochloride verapamil injection passed the consistency evaluation for generic drugs [18] - Shanghai Construction received approval for debt financing tools with a registration period of two years [20] Group 5 - Kangli Elevator terminated the sale of its wholly-owned subsidiary due to the buyer's failure to obtain necessary approvals [21] - Times Wan Heng appointed Li Zhizhong as the new deputy general manager [22] - Hanma Technology reported a total truck sales of 1,051 units in August, a year-on-year increase of 58.05% [24] Group 6 - Wenzhou Hongfeng's subsidiary received a utility model patent certificate for a servo adjustment device [26] - Yibin Technology received a project designation from a domestic new energy vehicle company, with an estimated total sales of 243 million yuan over five years [28] - Star Ring Technology's H-share issuance application was accepted by the China Securities Regulatory Commission [30] Group 7 - Microchip Bio's vice president resigned for personal reasons [31] - Zhongxin Co. announced the resignation of a non-independent director due to personal reasons [32] - Changcheng Military Industry's vice chairman resigned due to retirement [35] Group 8 - Jiukang Bio received four invention patent certificates related to detection reagents [36] - Meino Bio's subsidiary changed its registered address [37] - Kuangda Technology announced a potential change in control due to a share transfer [38] Group 9 - China Rare Earth confirmed no undisclosed significant matters amid stock price fluctuations [72]

Core Points - The company announced a cash dividend of RMB 0.09 per share (before tax) for its A shares [1] - The total number of shares eligible for the dividend distribution is 105,050,000 shares after excluding repurchased shares [2] - The total cash dividend to be distributed amounts to RMB 9,454,500 (before tax) [2] Dividend Distribution Plan - The profit distribution plan was authorized by the shareholders' meeting on May 19, 2025, and approved by the board of directors [1] - The cash dividend will be distributed to all shareholders registered on the equity registration date [1] - The reference price for ex-dividend trading will be calculated based on the previous closing price minus the cash dividend [2] Relevant Dates - The equity registration date is set for September 8, 2025 [2] - The last trading day before the ex-dividend date is September 9, 2025 [2] - The ex-dividend date is also September 9, 2025 [2] Taxation Information - Individual shareholders holding shares for over one year will not be subject to personal income tax on the dividend [5] - For shares held for less than one year, the tax will be calculated based on the holding period, with a maximum tax rate of 20% for shares held for one month or less [6] - For qualified foreign institutional investors (QFII), a withholding tax of 10% will apply to the dividend [7]

国浩律师（上海）事务所 国浩律师（上海）事务所 专项法律意见书 关于常州朗博密封科技股份有限公司 差异化分红事项之专项法律意见书 致：常州朗博密封科技股份有限公司 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民 共和国证券法》（以下简称"《证券法》"）、《上市公司股份回购规则》（以 下简称"《回购规则》"）、《上海证券交易所上市公司自律监管指引第7号— —回购股份》（以下简称"《回购指引》"）以及《常州朗博密封科技股份有限 公司章程》（以下简称"《公司章程》"）等相关法律、法规及规范性文件的规 定，本所律师就常州朗博密封科技股份有限公司（以下简称"公司"）2025年半 年度利润分配涉及的差异化权益分派特殊除权除息处理（以下简称"差异化分红"） 相关事项出具本专项法律意见书。 按照律师行业公认的业务标准、道德规范和勤勉尽责的精神，本所律师依据 本专项法律意见书出具日以前已发生或存在的事实和我国现行法律、法规和中国 证券监督管理委员会（以下简称"中国证监会"）的有关规定发表法律意见，并 声明如下： 1. 本所律师已严格履行了法定职责，遵循了勤勉尽责和诚实信用原则，根 据《公司法》《证券法》《回 ...

常州朗博密封科技股份有限公司2025年半年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利0.09元（含税） 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/9/8 | － | 2025/9/9 | 2025/9/9 | 证券代码：603655 证券简称：朗博科技 公告编号：2025-036 差异化分红送转： 是 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025 年 5 月 19 日的2024年年度股东大会授权公司董事会制定 实施，并经公司第四届董事会第三次会议审议通过，具体情况如下： 2025 年 5 月 19 日公司召开 2024 年年度股东大会，审议通过了《关于授权董事会制定中 期分红方案的议案》。 2025 年 8 月 12 日公司召开第四届董事会第三次会议，审议通过了《2025 年半年度利润 ...